Ads
related to: Pfizer
Search results
Pfizer profits drop on lower Covid-19 product sales
Ashley County Ledger· 1 hour agoPfizer reported a drop in profits on lower sales of Covid-19 related profits Wednesday as it steers investments to other pharmaceutical areas and...
Pfizer lifts profit view on cost cuts, higher COVID vaccine demand
Reuters· 2 hours ago, opens new tab lifted its annual profit forecast, banking on cost cuts, a smaller-than-feared drop...
Pfizer Earnings Top Views; Boosts Full-Year Guidance
Morningstar· 3 hours agoBy Rob Curran Pfizer posted first-quarter earnings and sales that topped Wall Street targets and boosted its full-year projections as sales of blood thinners and cancer drugs ...
Pfizer Sees Less Revenue From Covid-19 Treatments, Stock Faces Headwinds Ahead Of Q1 Earnings - ...
Benzinga· 23 hours agoPfizer's Q1 earnings report expects EPS of 49 cents and $13.09 billion in revenues. Stock has...
Pfizer beats revenue estimates, raises profit outlook on cost cuts and strong non-Covid sales
NBC Los Angeles· 6 hours agoPfizer reported first-quarter revenue that beat expectations and hiked its full-year profit outlook,...
Pfizer lifts profit view on cost cuts, smaller drop in Paxlovid demand
AOL· 3 hours agoShares of the U.S. drugmaker have lost 11% of their value this year on worries over its growth after the pandemic as billions of dollars in COVID vaccine and treatment sales evaporated. < ...
Pfizer: Q1 Earnings Snapshot
Associated Press Finance via Yahoo Finance· 3 hours agoNEW YORK (AP) — NEW YORK (AP) — Pfizer Inc. (PFE) on Wednesday reported first-quarter net income of $3.12 billion. The New York-based company said it had profit of 55 cents ...
Here's How to Play Pfizer (PFE) Stock Ahead of Q1 Earnings
Zacks via Yahoo Finance· 2 days agoPfizer (PFE) expects its operational revenues to improve, driven by its in-line products like...
Pfizer Lifts 2024 Profit View on Cost Cuts, Higher COVID Vaccine Demand
US News & World Report· 3 hours agoUS News is a recognized leader in college, grad school, hospital, mutual fund, and car rankings. Track elected officials, research health conditions, and find news you can use in politics, business, health, and education.
Pfizer and Genmab’s Tivdak wins full FDA approval for cervical cancer
Pharmaceutical Technology via Yahoo Finance· 24 hours agoPfizer and Genmab’s Tivdak (tisotumab vedotin-tftv) has won full approval from the US Food and Drug...
